News

U.S. gestational diabetes prevalence may be as high as 9.4%


 

FROM PREVENTING CHRONIC DISEASE

The rate of gestational diabetes in the United States is somewhere between 4.6% and 9.4%, according to investigators from the Centers for Disease Control and Prevention.

Researchers compared data from birth certificates collected from 16 states to data from the Pregnancy Risk Assessment Monitoring System (PRAMS) in 21 states. PRAMS is a CDC-led surveillance project that works with state health departments to collect population-based data on maternal experiences before, during, and after pregnancy.

In 2010, the prevalence of gestational diabetes mellitus was 4.6% as listed on birth certificates, 8.7% on the PRAMS scale, and 9.2% as reported on either the PRAMS scale or birth certificates. The percent agreement between the sources was 94.1%, wrote Carla L. DeSisto, M.P.H., and her associates at the CDC (Prev. Chronic Dis. 2014;11:130415 [doi:10.5888/pcd11.130415]).

There was no significant difference in gestational diabetes prevalence between the two study periods examined – 8.1% in 2007-08 and 8.5% in 2009-10, according to an analysis of PRAMS data from 123,373 women. In both time periods, Utah had the lowest prevalence (5.7% and 5.6%, respectively) and Rhode Island had the highest (10.4% and 11.7%).

mbock@frontlinemedcom.com

Recommended Reading

Bionic pancreas beat standard insulin pump in type 1 diabetes
Type 2 Diabetes ICYMI
Weight loss greater with higher-dose liraglutide in diabetes
Type 2 Diabetes ICYMI
Fatty heart may bring on diabetes
Type 2 Diabetes ICYMI
Cancer risk elevated before and 90 days after diabetes diagnosis
Type 2 Diabetes ICYMI
U.S. diabetes epidemic may be slowing
Type 2 Diabetes ICYMI
Insulin independence achieved with novel stem cell therapy
Type 2 Diabetes ICYMI
Closed-loop insulin delivery worked at home
Type 2 Diabetes ICYMI
Testosterone is Insulin Sensitizing in Diabetic Men With Hypogonadism
Type 2 Diabetes ICYMI
VIDEO: ADA unifies all pediatric HbA1c targets to less than 7.5%
Type 2 Diabetes ICYMI
ADA Unifies All Pediatric HbA1c Targets to Less Than 7.5%
Type 2 Diabetes ICYMI